Compare AANJANEYA LIFECARE with Sanofi India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS SANOFI INDIA DR. DATSONS LABS/
SANOFI INDIA
 
P/E (TTM) x -10.9 42.4 - View Chart
P/BV x 0.2 8.6 1.9% View Chart
Dividend Yield % 0.0 1.0 -  

Financials

 DR. DATSONS LABS   SANOFI INDIA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
SANOFI INDIA
Dec-18
DR. DATSONS LABS/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1266,840 1.8%   
Low Rs314,630 0.7%   
Sales per share (Unadj.) Rs133.01,203.1 11.1%  
Earnings per share (Unadj.) Rs0.2165.3 0.1%  
Cash flow per share (Unadj.) Rs6.6209.9 3.1%  
Dividends per share (Unadj.) Rs084.00 0.0%  
Dividend yield (eoy) %01.5 0.0%  
Book value per share (Unadj.) Rs128.8963.6 13.4%  
Shares outstanding (eoy) m31.6623.03 137.5%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.8 12.3%   
Avg P/E ratio x516.134.7 1,487.3%  
P/CF ratio (eoy) x11.827.3 43.3%  
Price / Book Value ratio x0.66.0 10.2%  
Dividend payout %050.8 0.0%   
Avg Mkt Cap Rs m2,477132,078 1.9%   
No. of employees `000NA3.3 0.0%   
Total wages/salary Rs m564,068 1.4%   
Avg. sales/employee Rs ThNM8,393.8-  
Avg. wages/employee Rs ThNM1,232.4-  
Avg. net profit/employee Rs ThNM1,153.0-  
INCOME DATA
Net Sales Rs m4,21127,708 15.2%  
Other income Rs m79897 8.8%   
Total revenues Rs m4,28928,605 15.0%   
Gross profit Rs m5696,235 9.1%  
Depreciation Rs m2041,027 19.9%   
Interest Rs m4307 6,145.7%   
Profit before tax Rs m136,098 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m62,292 0.3%   
Profit after tax Rs m53,806 0.1%  
Gross profit margin %13.522.5 60.0%  
Effective tax rate %48.037.6 127.8%   
Net profit margin %0.113.7 0.8%  
BALANCE SHEET DATA
Current assets Rs m6,85215,922 43.0%   
Current liabilities Rs m6,7116,235 107.6%   
Net working cap to sales %3.335.0 9.6%  
Current ratio x1.02.6 40.0%  
Inventory Days Days16164 252.7%  
Debtors Days Days31821 1,526.3%  
Net fixed assets Rs m3,6737,539 48.7%   
Share capital Rs m317230 137.7%   
"Free" reserves Rs m3,76121,962 17.1%   
Net worth Rs m4,07822,192 18.4%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63329,839 42.3%  
Interest coverage x1.0872.1 0.1%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.30.9 35.9%   
Return on assets %3.412.8 26.9%  
Return on equity %0.117.2 0.7%  
Return on capital %7.727.5 27.9%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m9647,587 12.7%   
Fx outflow Rs m6077,145 8.5%   
Net fx Rs m357442 80.7%   
CASH FLOW
From Operations Rs m1,3453,739 36.0%  
From Investments Rs m-2,256-731 308.6%  
From Financial Activity Rs m-1,200-1,972 60.8%  
Net Cashflow Rs m-2,1111,036 -203.7%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 0.0 14.4 -  
FIIs % 1.4 14.6 9.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 10.5 896.2%  
Shareholders   20,807 15,184 137.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   NOVARTIS  TORRENT PHARMA  DISHMAN PHARMA  CIPLA  ASTRAZENECA PHARMA  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens above 50,000-Mark; Tata Motors & Bajaj Finance Top Gainers(09:30 am)

Asian share markets rose for the third straight session today, tracking gains in US peers. The Nikkei is trading up by 0.7% and the Hang Seng is trading up by 0.1%.

Related Views on News

SANOFI INDIA Announces Quarterly Results (2QFY21); Net Profit Up 5.0% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 5.0% YoY). Sales on the other hand came in at Rs 7 bn (down 11.9% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY21); Net Profit Up 39.9% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY20); Net Profit Down 8.1% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, SANOFI INDIA has posted a net profit of Rs 854 m (down 8.1% YoY). Sales on the other hand came in at Rs 8 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - NOVARTIS COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS